Source: Real Money Valeant Pharmaceuticals' (VRX) new CEO Joseph Papa may have spoken too soon in his pledge to begin…...
Latest News
Journey Medical Corporation Launches Luxamend™ Wound Cream and Ceracade™ Skin Barrier Emulsion
Source: CNBC Journey Medical Corporation, a subsidiary of Fortress Biotech, Inc. (FBIO), launched the first two prescription products in its…...
Valeant’s Ex-CEO Michael Pearson Sells Nearly $100 Million in Company Stock
Source: The Wall Street Journal Michael Pearson has sold nearly $100 million of his stock in Valeant Pharmaceuticals International Inc.…...
Galderma Announces FDA Approval of Full Prescription-Strength Differin® Gel For Over-the-Counter Acne Use
Source: Galderma, a global leader focused on medical solutions in skin health, today announced that its U.S. affiliate, Galderma Laboratories,…...
LEO buys rights to AstraZeneca’s skin drug
Source: LEO Pharma has entered a strategic partnership with AstraZeneca for new medicines for atopic dermatitis and psoriasis, major skin…...
Mayne vaults ahead in U.S. with $652M deal for Teva/Allergan meds
Source: Teva’s massive agreement to buy Allergan’s generics business continues to ripple its way through the industry. Australia’s Mayne Pharma…...
Pfizer Completes Acquisition of Anacor
Source: Business Wire Pfizer Inc. (NYSE:PFE) today announced that it has completed its acquisition of Anacor Pharmaceuticals, Inc. Under the…...
Sun Pharma bets on new products to boost U.S. skincare products growth
Source: By Zeba Siddiqui MUMBAI (Reuters) - India's largest drugmaker Sun Pharmaceutical Industries is banking on the launch of newer…...
Essex Woodlands backs San Diego dermal filler startup with $25M
Source: FierceMedicalDevice Healthcare growth investor Essex Woodlands has backed Suneva Medical with a new $25 million financing aimed at expanding…...
Microsoft to buy LinkedIn for $26.2 billion in its largest deal
Source: Reuters Microsoft Corp will buy LinkedIn Corp for $26.2 billion in its biggest-ever deal, a bold stroke by Microsoft…...